MAHANEY PAIGE (Chief Scientific Officer) received a stock award from C4 THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/18/2025ACC: 0001662579-25-000015
Officer· Chief Scientific Officer
Since Feb 2026
+70.60K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
70.60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28.20K
Price / share
—
Trade value
—
% of position
36.7%
2/14/2025
76.80K→105K
Total
Net shares
+28.20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/14/2025 | A · Award | +28.20K | — | — | 36.7% | 76.80K | 105K |
| Total | +28.20K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
42.40K shares
Shares
+42.40K
Strike price
3.18
Held after
42.40K
Exercisable
—
2/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock42.40K shares | 2/14/2025 | A · Award | +42.40K | 3.18 | — | 42.40K |